|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Tracking Information | |
|---|---|
| First Received Date ICMJE | March 21, 2006 |
| Last Updated Date | September 19, 2006 |
| Start Date ICMJE | March 2006 |
| Primary Completion Date | |
| Current Primary Outcome Measures ICMJE |
Negative urease breath test at five weeks post procedure |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT00306280 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE |
|
| Original Secondary Outcome Measures ICMJE | Same as current |
| Descriptive Information | |
| Brief Title ICMJE | Feasibility Study of Phototherapy System to Treat H Pylori |
| Official Title ICMJE | Phase 1 Study of Phototherapy System to Treat H Pylori |
| Brief Summary | This purpose of this study is to determine whether phototherapy can be used to safely and effectively treat H pylori. |
| Detailed Description | H pylori causes almost all peptic ulcers and many gastric cancers and is widely prevalent worldwide. Treatment by multiple antibiotics and proton pump inhibitors is effective but are compromised today by significant non compliance due to side effects and duration of required treatment. Also, the increase in antibiotic resistance coupled with the decreased availability of new antibiotics project a significant population of patients who will not be treatable with antibiotics. A special, visible-light based phototherapy system has been demonstrated to significantly decrease the viability of H pylori in vitro and in a brief clinical experiment. This study will evaluate the safety and short term efficacy in up to 60 patients of the phototherapy system to treat H pylori. |
| Study Phase | |
| Study Type ICMJE | Interventional |
| Study Design ICMJE | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Condition ICMJE | Helicobacter Pylori |
| Intervention ICMJE | Device: Phototherapy |
| Study Arms / Comparison Groups | |
| Publications * | |
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Recruiting |
| Enrollment ICMJE | 60 |
| Completion Date | March 2007 |
| Primary Completion Date | |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 18 Years to 90 Years |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | |
| Location Countries ICMJE | United States |
| Administrative Information | |
| NCT ID ICMJE | NCT00306280 |
| Responsible Party | |
| Study ID Numbers ICMJE | lmrx01 |
| Study Sponsor ICMJE | LumeRx |
| Collaborators ICMJE | |
| Investigators ICMJE | |
| Information Provided By | LumeRx |
| Verification Date | September 2006 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|